The immense pressure of COVID-19 has put on societies worldwide, pharmaceutical companies strive to make rapid test devices available to the public urgently.
Due to their experience with biosensors and their reputation of creating reliable systems, SPGPrints was invited in the development and delivery of several production lines to produce COVID-19 rapid test strips. Millions of test strips are expected to be produced on both production lines, in which way SPGPrints contributes to a solution for the increased global demand for more test capacity.
Hank Guitjens, Commercial Manager Label & Industrial printing at SPGPrints explains,“the usage of biosensors around the world is not new. For over 30 years, biosensors are a quick tool for analyzing diseases, using just a strip and body fluids. A common application of biosensors in the medical industry are the glucose test strips for diabetes patients. They use these strips to test if their blood sugar levels are deviating from normal. To provide the patient with quick test results, the blood is dripped on a test strip which is then examined by a diagnostic test device. Within minutes, the patient can see what their exact levels are”.
SPGPrints developed, produced and delivered a custom-made system for their pharmaceutical partner. Despite it being a new, custom-made system, the startup phase was very successful, and a yield was achieved above expectation within weeks. The training given to the newly hired operators for the user-friendliness of the system, enabled the pharmaceutical partner to reach their ideal production levels within weeks after the new system had been delivered.
|
